MoneyWorks4Me

A decrease in the sales to Rs. 5595.30 millions was observed for the quarter ended March 2024. The sales stood at Rs. 6964.10 millions during the similar quarter previous year.The Company to register a -32.03%  fall in the net profit for the quarter ended March 2024.The company reported a degrowth in operating Profit to 701.70 millions from 894.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5595.30 6964.10 -19.66 22669.10 24979.70 -9.25 22669.10 24979.70 -9.25
Other Income 11.10 9.30 19.35 41.80 22.30 87.44 41.80 22.30 87.44
PBIDT 701.70 894.50 -21.55 2703.10 2846.30 -5.03 2703.10 2846.30 -5.03
Interest 80.90 83.50 -3.11 301.60 325.30 -7.29 301.60 325.30 -7.29
PBDT 620.80 811.00 -23.45 2401.50 2521.00 -4.74 2401.50 2521.00 -4.74
Depreciation 123.40 116.80 5.65 476.70 472.90 0.80 476.70 472.90 0.80
PBT 497.40 694.20 -28.35 1924.80 2048.10 -6.02 1924.80 2048.10 -6.02
TAX 136.00 162.50 -16.31 506.00 520.00 -2.69 506.00 520.00 -2.69
Deferred Tax -15.00 -15.00 0.00 10.00 -12.50 -180.00 10.00 -12.50 -180.00
PAT 361.40 531.70 -32.03 1418.80 1528.10 -7.15 1418.80 1528.10 -7.15
Equity 919.40 926.00 -0.71 919.40 926.00 -0.71 919.40 926.00 -0.71
PBIDTM(%) 12.54 12.84 -2.36 11.92 11.39 4.65 11.92 11.39 4.65
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..